India, Oct. 16 -- This week's healthcare roundup brings a series of regulatory wins, corporate restructuring, billion-dollar deals and clinical milestones.
Roche and Teva gained FDA approvals, while Mesa Laboratories and GSK moved ahead with workforce cuts. Strategic moves also took center stage, with Labcorp, AstraZeneca, Galderma and Zealand Pharma announcing notable acquisitions and collaborations.
Clinical updates added further momentum, with companies reporting promising findings in several disease areas alongside trial setbacks that could reshape development plans.
Let us unpack this week's key healthcare developments.
Approvals
Roche Expands Enspryng's Reach with FDA Approval for Thyroid Eye Disease
Roche Holding AG (RHHBY) rec...